SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001683541-24-000005
Filing Date
2024-02-08
Accepted
2024-02-08 07:10:27
Documents
11
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 6-K form6-k20231231q32024.htm 6-K 12155
2 EX-99.1 fs20231231q32024.htm EX-99.1 990186
3 EX-99.2 mda20231231q32024.htm EX-99.2 739833
4 EX-99.3 a993certificationofceo.htm EX-99.3 4767
5 EX-99.4 a994certificationofcfo.htm EX-99.4 4762
6 a993certificationofceo001.jpg GRAPHIC 221560
7 a993certificationofceo002.jpg GRAPHIC 68154
8 a994certificationofcfo001.jpg GRAPHIC 221310
9 a994certificationofcfo002.jpg GRAPHIC 67640
10 auroralogoa02.gif GRAPHIC 17796
11 mda2019imagea04a.gif GRAPHIC 17796
  Complete submission text file 0001683541-24-000005.txt   2599314
Mailing Address 409 GRANVILLE STREET SUITE 1700 VANCOUVER A1 V6C 1T2
Business Address 2207 90B STREET SW EDMONTON A0 T6X 1V8 604-362-5207
AURORA CANNABIS INC (Filer) CIK: 0001683541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38691 | Film No.: 24606844
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)